The volume of Portuguese cannabis exports almost tripled in 2024 compared to the previous year. According to data provided to ECO by the National Authority for Medicines and Health Products ( Infarmed ...

European Commodity Winners This Week IBEX 35 Mini (May 2025) (EZK25), +6% About 25% of the index is represented by European ...

Q1 2025 Management View CEO Chris Boerner highlighted a strong start to 2025 with $11.2 billion in total revenue, driven by ...

The 6th Gene Therapy Analytical Development Summit Europe, taking place from 20 th – 22 nd May 2025 in London, returns as the only European forum solely dedicated to tackling the analytical and ...

In this episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance ...

Dyne Therapeutics (DYN) announced that the European Commission has granted orphan drug designation for DYNE-251 for the treatment of Duchenne ...

Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months - - Data from the fully enrolled DELIVER registrational expansion cohort is planned for ...

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

Chainlink (LINK) has been one of the best-performing tokens in the past 24 hours as has delivered gains of 7.3% and currently sits at $14.9 per token.

Biotech stock Scholar Rock (NASDAQ: SRRK) was popular among investors on Wednesday after a positive new analyst note on the ...

Amtagvi® and its accompanying design marks, Proleukin ®, Iovance ®, and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other ...

Obe-cel is under regulatory review in both the EU and the U.K., and the Company expects to receive notification of approval status from the Medicines and Healthcare products Regulatory Agency (MHRA) ...